Ultomiris
Payments companies reported to CMS as associated with Ultomiris. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ultomiris, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ultomiris
These are the largest totals companies reported as associated with Ultomiris. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Perry Shieh | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $219,443.93 |
| Tuan Vu | Tampa, FL | Neurology (Psychiatry & Neurology) | $215,581.98 |
| Joshua Alpers | Chattanooga, TN | Neuromuscular Medicine (Psychiatry & Neurology) | $173,659.81 |
| Jeffrey Laurence | New York, NY | Hematology & Oncology | $172,879.13 |
| Ruth Fredericks | Jackson, MS | Neurology (Psychiatry & Neurology) | $172,557.19 |
| Bhupendra Khatri | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $170,794.21 |
| Suraj Muley | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $155,838.11 |
| Andrew Gordon | Lake Barrington, IL | Neurology (Psychiatry & Neurology) | $152,123.39 |
| Christopher Scheiner | Dayton, OH | Neurology (Psychiatry & Neurology) | $128,748.31 |
| Dennis Deruelle | Knoxville, TN | Internal Medicine | $109,043.66 |
Prescribed Ultomiris?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.